A research study funded by the Juvenile Diabetes Research Foundation (JDRF) suggests that a common intestinal bacteria may provide some protection from developing Type 1 diabetes. The findings provide an important step towards understanding how and why Type 1 diabetes develops in people, and may lead to potential cures.
The study, reported this week in the journal Nature, lends further support to the "hygiene hypothesis," that exposure to an appropriate amount and composition of bacteria may be important to living a healthy life, and that susceptibility to Type 1 diabetes and other autoimmune disorders may actually be caused by a lack of exposure to certain parasites and microbes.
In the study, researchers at YaleUniversity and the University of Chicago found that exposure to certain bacteria will trigger an immune system response in mice. That response is believed to be what prevents autoimmune disorders -- conditions where the immune system attacks healthy cells in the body. In people with Type 1 diabetes, the immune system attacks the beta cells in the pancreas, stopping a person's ability to detect glucose and produce insulin. For the purposes of the study, the bacteria used were harmless microbes typically found in the human intestine. The scientists suggest that safe, measured exposure to certain bacteria may lower the risk of immune disorders.
"This study outcome gives us a new avenue to explore," said JDRF executive vice president of research Richard A. Insel, MD. "And, with type 1 diabetes in the U.S. and many countries around the world at about a 3 percent annual rate, every lead is significant. The research gives impetus to better understanding how the bacterial flora in our body influences host immune defenses and responses that provide resistance to the development of Type 1 diabetes. This understanding may provide new therapeutic approaches to prevention."
For the study, teams led by Li Wen at Yale and Alexander V. Chervonsky at the University of Chicago used mice that under normal conditions, would not develop diabetes. If raised in a germ-free environment, however, the mice developed diabetes. But mice that were exposed to common intestinal bacteria maintained a lower risk for the disease.
Source: Juvenile Diabetes Research Foundation
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.